212 related articles for article (PubMed ID: 30055803)
1. Autophagy is involved in acetylshikonin ameliorating non-alcoholic steatohepatitis through AMPK/mTOR pathway.
Zeng J; Zhu B; Su M
Biochem Biophys Res Commun; 2018 Sep; 503(3):1645-1650. PubMed ID: 30055803
[TBL] [Abstract][Full Text] [Related]
2. Alisol A 24-acetate ameliorates nonalcoholic steatohepatitis by inhibiting oxidative stress and stimulating autophagy through the AMPK/mTOR pathway.
Wu C; Jing M; Yang L; Jin L; Ding Y; Lu J; Cao Q; Jiang Y
Chem Biol Interact; 2018 Aug; 291():111-119. PubMed ID: 29883724
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol ameliorates hepatic steatosis and inflammation in methionine/choline-deficient diet-induced steatohepatitis through regulating autophagy.
Ji G; Wang Y; Deng Y; Li X; Jiang Z
Lipids Health Dis; 2015 Oct; 14():134. PubMed ID: 26498332
[TBL] [Abstract][Full Text] [Related]
4. GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway.
He Q; Sha S; Sun L; Zhang J; Dong M
Biochem Biophys Res Commun; 2016 Aug; 476(4):196-203. PubMed ID: 27208776
[TBL] [Abstract][Full Text] [Related]
5. Antagonizing circRNA_002581-miR-122-CPEB1 axis alleviates NASH through restoring PTEN-AMPK-mTOR pathway regulated autophagy.
Jin X; Gao J; Zheng R; Yu M; Ren Y; Yan T; Huang Y; Li Y
Cell Death Dis; 2020 Feb; 11(2):123. PubMed ID: 32054840
[TBL] [Abstract][Full Text] [Related]
6. Scoparone improves hepatic inflammation and autophagy in mice with nonalcoholic steatohepatitis by regulating the ROS/P38/Nrf2 axis and PI3K/AKT/mTOR pathway in macrophages.
Liu B; Deng X; Jiang Q; Li G; Zhang J; Zhang N; Xin S; Xu K
Biomed Pharmacother; 2020 May; 125():109895. PubMed ID: 32000066
[TBL] [Abstract][Full Text] [Related]
7. Baicalin attenuates non-alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, inflammation and fibrosis in mice.
Zhang J; Zhang H; Deng X; Zhang N; Liu B; Xin S; Li G; Xu K
Life Sci; 2018 Jan; 192():46-54. PubMed ID: 29158052
[TBL] [Abstract][Full Text] [Related]
8. Protective role of autophagy in methionine-choline deficient diet-induced advanced nonalcoholic steatohepatitis in mice.
Chen R; Wang Q; Song S; Liu F; He B; Gao X
Eur J Pharmacol; 2016 Jan; 770():126-33. PubMed ID: 26593434
[TBL] [Abstract][Full Text] [Related]
9. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
Ding Y; Sun X; Chen Y; Deng Y; Qian K
Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348
[TBL] [Abstract][Full Text] [Related]
10. Betaine modulates oxidative stress, inflammation, apoptosis, autophagy, and Akt/mTOR signaling in methionine-choline deficiency-induced fatty liver disease.
Veskovic M; Mladenovic D; Milenkovic M; Tosic J; Borozan S; Gopcevic K; Labudovic-Borovic M; Dragutinovic V; Vucevic D; Jorgacevic B; Isakovic A; Trajkovic V; Radosavljevic T
Eur J Pharmacol; 2019 Apr; 848():39-48. PubMed ID: 30689995
[TBL] [Abstract][Full Text] [Related]
11. Gemigliptin, a DPP4 inhibitor, ameliorates nonalcoholic steatohepatitis through AMP-activated protein kinase-independent and ULK1-mediated autophagy.
Song Y; Yang H; Kim J; Lee Y; Kim SH; Do IG; Park CY
Mol Metab; 2023 Dec; 78():101806. PubMed ID: 37739179
[TBL] [Abstract][Full Text] [Related]
12. Demethyleneberberine attenuates non-alcoholic fatty liver disease with activation of AMPK and inhibition of oxidative stress.
Qiang X; Xu L; Zhang M; Zhang P; Wang Y; Wang Y; Zhao Z; Chen H; Liu X; Zhang Y
Biochem Biophys Res Commun; 2016 Apr; 472(4):603-9. PubMed ID: 26970305
[TBL] [Abstract][Full Text] [Related]
13. Neuregulin 4 alleviates hepatic steatosis via activating AMPK/mTOR-mediated autophagy in aged mice fed a high fat diet.
Zhu B; Mei W; Jiao T; Yang S; Xu X; Yu H; Ding Y; Guo S; Meng B; Zhao L; He M; Dong K; Guo H; Guo X; Zhang H; Dang R; Xiang G; Wen N
Eur J Pharmacol; 2020 Oct; 884():173350. PubMed ID: 32726654
[TBL] [Abstract][Full Text] [Related]
14. Terf2ip deficiency accelerates non-alcoholic steatohepatitis through regulating lipophagy and fatty acid oxidation via Sirt1/AMPK pathway.
Wang Y; Liu S; Ni M; Chen Y; Chen R; Wang J; Jiang W; Zhou T; Fan S; Chang J; Xu X; Zhang Y; Yu Y; Li X; Li C
Free Radic Biol Med; 2024 Aug; 220():78-91. PubMed ID: 38697492
[TBL] [Abstract][Full Text] [Related]
15. Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibition.
Kim SH; Kim G; Han DH; Lee M; Kim I; Kim B; Kim KH; Song YM; Yoo JE; Wang HJ; Bae SH; Lee YH; Lee BW; Kang ES; Cha BS; Lee MS
Autophagy; 2017 Oct; 13(10):1767-1781. PubMed ID: 28933629
[TBL] [Abstract][Full Text] [Related]
16. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis.
Lee DH; Han DH; Nam KT; Park JS; Kim SH; Lee M; Kim G; Min BS; Cha BS; Lee YS; Sung SH; Jeong H; Ji HW; Lee MJ; Lee JS; Lee HY; Chun Y; Kim J; Komatsu M; Lee YH; Bae SH
Free Radic Biol Med; 2016 Oct; 99():520-532. PubMed ID: 27634173
[TBL] [Abstract][Full Text] [Related]
17. Over-expressing the soluble gp130-Fc does not ameliorate methionine and choline deficient diet-induced non alcoholic steatohepatitis in mice.
Kammoun HL; Allen TL; Henstridge DC; Kraakman MJ; Peijs L; Rose-John S; Febbraio MA
PLoS One; 2017; 12(6):e0179099. PubMed ID: 28632778
[TBL] [Abstract][Full Text] [Related]
18. CXC chemokine receptor 3 promotes steatohepatitis in mice through mediating inflammatory cytokines, macrophages and autophagy.
Zhang X; Han J; Man K; Li X; Du J; Chu ES; Go MY; Sung JJ; Yu J
J Hepatol; 2016 Jan; 64(1):160-70. PubMed ID: 26394162
[TBL] [Abstract][Full Text] [Related]
19. Hydrogen sulfide reduces serum triglyceride by activating liver autophagy via the AMPK-mTOR pathway.
Sun L; Zhang S; Yu C; Pan Z; Liu Y; Zhao J; Wang X; Yun F; Zhao H; Yan S; Yuan Y; Wang D; Ding X; Liu G; Li W; Zhao X; Liu Z; Li Y
Am J Physiol Endocrinol Metab; 2015 Dec; 309(11):E925-35. PubMed ID: 26442880
[TBL] [Abstract][Full Text] [Related]
20. Activation of AMPK by triptolide alleviates nonalcoholic fatty liver disease by improving hepatic lipid metabolism, inflammation and fibrosis.
Huang R; Guo F; Li Y; Liang Y; Li G; Fu P; Ma L
Phytomedicine; 2021 Nov; 92():153739. PubMed ID: 34592488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
